We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

OPY:NYSEOppenheimer Holdings, Inc. Analysis

Data as of 2026-07-08 - not real-time

$113.97

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Oppenheimer Holdings (OPY) is trading at $113.97, comfortably above its 20‑day SMA of $106.48 and the 50‑day SMA of $101.40, while the 200‑day SMA sits near $85, underscoring a strong long‑term uptrend. Technical momentum is reinforced by a bullish MACD crossover (line $3.39 above signal $2.72) and an RSI of 64, indicating continued buying pressure without yet being overbought. Volume has been increasing, and the stock is holding above a key support level near $97.33 with resistance around $118.60, suggesting room for upside. Fundamentally, the stock trades at a trailing PE of 13.6 versus an industry average of 17.7, and the DCF‑derived fair value of $203.9 implies a >75% discount to current price, pointing to deep undervaluation. The company boasts a robust cash pile of $1.46 B against $1.40 B of debt, a low dividend payout ratio of ~8.6%, and a modest ROE of 10.5%, supporting dividend sustainability. Recent bullish sentiment from a TradersPro Substack thesis and a Yahoo Finance note highlighting the cheap PE and cash strength further reinforce the upside narrative.
Strategically, Oppenheimer’s launch of coverage for SpaceX signals a willingness to engage in high‑growth, high‑visibility deals, potentially expanding its capital‑markets franchise and enhancing fee revenue over the medium to long term.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical indicators (price above SMA20/50, bullish MACD, RSI in healthy range)
  • Significant discount to DCF fair value
  • Strong cash position and low dividend payout supporting upside

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Solid fundamentals with healthy profit margins and cash reserves
  • Elevated forward PE indicating earnings pressure
  • Continued volatility (45% 30‑day) requiring cautious positioning

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Deep undervaluation relative to intrinsic DCF value
  • Strategic growth opportunities from new high‑profile coverage (e.g., SpaceX)
  • Sustainable dividend supported by strong balance sheet

Key Metrics & Analysis

Financial Health

Revenue Growth23.10%
Profit Margin5.96%
P/E Ratio13.6
ROE10.53%
ROA2.62%
Debt/Equity145.37
P/B Ratio1.3
Op. Cash Flow$90.5M
Industry P/E17.7

Technical Analysis

TrendBullish
RSI63.7
Support$97.33
Resistance$118.60
MA 20$106.48
MA 50$101.40
MA 200$85.09
MACDBullish
VolumeIncreasing
Fear & Greed Index92.63

Valuation

Fair Value$203.91
GradeUndervalued
TypeValue
Dividend Yield0.69%

Risk Assessment

Beta1.00
Volatility45.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.